Although, TrkC‐miR2‐5p‐GC was relatively expressed at low level in most of the examined brain cancer biopsies, the highest expression level of it was detected in glioma biopsies (Figure 3B,C) compared with meningioma transition type 1 tissue samples as the control. The gene discussed is NTRK3; the disease is central nervous system cancer.